Abstract
Bioassay record of High Throughput Screening (HTS) contains compounds with high diversity. This high diversity in molecules causes an intense non-linearity into the molecular descriptors set. So to build a QSAR model covering the diversity in molecular structure is a tedious task. In the present work, a method has been proposed to extract information about pharmacophores covering a larger area in the HTS record and development of Support Vector Regression (SVR) QSAR model considering extracted pharmacophores specified to the cell line or target. A probabilistic approach has also been proposed to evaluate the authenticity of predictions made by QSAR model. The developed method has been used for virtual screening of library molecules. The advantage of this protocol is that, it is beneficial for a very large dataset. The proposed method has the capability to extract pharmacophore information from any HTS data. Additionally, this will be advantageous for the development of précised virtual screening model on the basis of high throughput screening data.
Keywords: Cluster, HTS, pharmacophore, QSAR, SVR.
Combinatorial Chemistry & High Throughput Screening
Title:Cluster Based SVR-QSAR Modelling for HTS Records: An Implementation for Anticancer Leads Against Human Breast Cancer
Volume: 16 Issue: 7
Author(s): Om Prakash and Feroz Khan
Affiliation:
Keywords: Cluster, HTS, pharmacophore, QSAR, SVR.
Abstract: Bioassay record of High Throughput Screening (HTS) contains compounds with high diversity. This high diversity in molecules causes an intense non-linearity into the molecular descriptors set. So to build a QSAR model covering the diversity in molecular structure is a tedious task. In the present work, a method has been proposed to extract information about pharmacophores covering a larger area in the HTS record and development of Support Vector Regression (SVR) QSAR model considering extracted pharmacophores specified to the cell line or target. A probabilistic approach has also been proposed to evaluate the authenticity of predictions made by QSAR model. The developed method has been used for virtual screening of library molecules. The advantage of this protocol is that, it is beneficial for a very large dataset. The proposed method has the capability to extract pharmacophore information from any HTS data. Additionally, this will be advantageous for the development of précised virtual screening model on the basis of high throughput screening data.
Export Options
About this article
Cite this article as:
Prakash Om and Khan Feroz, Cluster Based SVR-QSAR Modelling for HTS Records: An Implementation for Anticancer Leads Against Human Breast Cancer, Combinatorial Chemistry & High Throughput Screening 2013; 16 (7) . https://dx.doi.org/10.2174/1386207311316070002
DOI https://dx.doi.org/10.2174/1386207311316070002 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteinase-Activated Receptor-2: Physiological and Pathophysiological Roles
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Anti-HER2 Therapy in Elderly Breast Cancer Patients
Reviews on Recent Clinical Trials Plant Proteinases and Inhibitors: An Overview of Biological Function and Pharmacological Activity
Current Protein & Peptide Science Foods for Health and to Treat Diseases
Current Pediatric Reviews Therapeutic Targeting of Amyloid Precursor Protein and its Processing Enzymes for Breast Cancer Treatment
Current Protein & Peptide Science Adiponectin: A Key Player in Obesity Related Disorders
Current Pharmaceutical Design Molecular Mechanisms Underlying Psychological Stress and Cancer
Current Pharmaceutical Design microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology Recent Patents on Physical, Mineral & Organic Acid Composition of Golden Delicious and Red Delicious Apples (Malus×Domestica Borkh) Grown in the West of Iran
Recent Patents on Food, Nutrition & Agriculture Biosynthetic and Metabolic Alterations in Cancer Growth
Current Angiogenesis (Discontinued) Effects of Endocrine Disruptors on Developmental and Reproductive Functions
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Cyclodepsipeptides - Potential Drugs and Lead Compounds in the Drug Development Process
Current Medicinal Chemistry Surgical Treatment in FIGO Stage I Cervical Cancer: Evolution of Concepts
Current Women`s Health Reviews The Functions of Heparanase in Human Diseases
Mini-Reviews in Medicinal Chemistry Roles of Secreted Phospholipases A<sub>2</sub> in the Mammalian Immune System
Protein & Peptide Letters Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer
Current Medicinal Chemistry Current Concepts for the Combined Treatment Modality of Ionizing Radiation with Anticancer Agents
Current Pharmaceutical Design Peptide Activators of the p53 Tumor Suppressor
Current Pharmaceutical Design Chemical and Radiochemical Considerations in Radiolabeling with α-Emitting Radionuclides
Current Radiopharmaceuticals Inorganic Phosphate as a Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment
Current Pharmaceutical Design